Thermophilic L-asparaginases display high stability and activity at elevated temperatures. However, they are of limited use in leukemia therapy because of their low substrate affinity and reduced activity under physiological conditions. In an attempt to combine stability with activity at physiological conditions, 3 active-site mutants of Pyrococcus furiosus L-asparaginase (PfA) were developed. The mutants, specifically K274E, showed improved enzymatic properties at physiological conditions as compared to the wild type. All variants were thermodynamically stable and resistant to proteolytic digestion. None of the enzymes displayed glutaminase activity, a highly desirable therapeutic property. All variants showed higher and significant killing of human cell lines HL60, MCF7, and K562 as compared to the Escherichia coli L-asparaginase. Our study revealed that increased substrate accessibility through the active site loop plays a major role in determining activity. A new mechanistic insight has been proposed based on molecular dynamics simulated structures, where dynamic flipping of a critical Tyr residue is responsible for the activity of thermophilic L-asparaginases. Our study not only resulted in development of PfA mutants with combination of desirable properties but also gave a mechanistic insight about their
Stability of proteins is a desirable characteristic, irrespective of whether it is used in biotechnological research or industrial applications or for therapeutic purposes. For increasing stability, protein modification approaches such as directed evolution (1), site-directed mutagenesis (2, 3) , chemical and physical modifications like PEGylation, encapsulation (4, 5) , and addition of extraneous stabilizing agents (6) have been reported with various degrees of success. Thermophilic proteins are generally resistant against a variety of harsh physicochemical conditions. They display exceptional stability and optimum activity at high temperature, making them favored industrial enzymes. Reports of thermophilic enzymes being used as diagnostic biosensors also exist (7); however, their applicability in therapeutic purposes remains far from reach. This is because enzymes for therapeutic purposes should work ideally at physiological conditions, while thermophilic enzymes act optimally at high temperatures. An ideal scenario therefore is to combine the stability of thermophilic enzymes with mesoactivity.
In this study, l-asparaginase (l-asparagine amidohydrolase; EC 3.5.1.1) is used as a model enzyme for the purpose stated above. The enzyme is obtained from plant, animal, bacterial, and fungal sources (8 -15) . Although primarily used as chemotherapeutic agent against leukemia, the enzyme is also used for a variety of other purposes (16 -18) . The antileukemic activity is because of depletion of l-asparagine in the blood, where the survival of leukemic cells depends on the availability of external asparagine. The enzymes are also used in other kinds of leukemia, such as Hodgkin's lymphoma, acute myelocytic and myelomonocytic leukemia, and chronic lymphocytic leukemia, and sarcomas such as lymphosarcoma, reticulosarcoma, and melanosarcoma (11, 19, 20) . At present, clinically useful l-asparaginases are obtained from either Escherichia coli [E. coli l-asparaginase II (EcA II)] or Erwinia chrysanthemi [E. crysanthemi l-asparagianse (ErA)]. Enzymes from these mesophilic sources have an associated glutaminase activity that causes side effects (21, 22) . Apart from severe immunogenic reactions, several adverse effects of l-asparaginase treatment have also been reported (5) . Extensive and prolonged asparaginase treatment causes liver damage, acute pancreatitis, and coagulation abnormalities (23) . Further, these enzymes have low stability and reduced half-life in the blood, requiring multiple-dose administration, which leads to higher side effects and high cost of treatment (2, (22) (23) (24) (25) (26) . To counter these drawbacks, protein engineering approaches have been taken to enhance thermal stability, substrate specificity, and resistance to proteolysis. In these approaches, the overall architecture of mesophilic enzyme remained conserved (2, 3, 22, 27, 28) . In contrast, a reverse approach to obtain mesoactivity keeping the overall stable scaffold of the archeal enzyme has not yet been attempted.
Such an attempt has been made in the present study on Pyrococcus furiosus l-asparaginase (PfA) to combine thermostability with mesoactivity. Previously we reported that PfA is a dimer and possesses high K m value and activity at elevated temperatures (29) . For improving the enzymatic properties at 37°C, a rational approach has been taken, and selective mutations have been made. The mutational sites were selected on the basis of sequence and structural comparison between EcA II and PfA. Our study revealed that flexibility of an active site loop structure discriminates functionality of the enzymes. Our studies also resulted in closer insights of active site and led us to propose the presence of an altogether new catalytic triad operating in thermophilic asparaginases. This proposed catalytic triad is not only composed of different sets of residues but also represents dynamic flipping mechanism of a critical Tyr residue. We also found that Asp84 of this proposed new triad is a common acidic residue for the second catalytic triad typical of asparaginases. Beside this, the mutants showed significant cytotoxicity on cultured human leukemic cell lines. Similar to recombinant wild-type (WT) PfA, the mutants also displayed considerable stability at high temperature without any glutaminase activity. Absence of glutaminase activity, higher stability, and mesoactivity makes PfA and its mutants promising candidates for clinical as well as industrial usage.
MATERIALS AND METHODS

Selection of residues
For identification of residues to be mutated, sequence and structure-based comparisons of PfA with known l-asparaginases were performed. Sequence comparison between the putative amino acid sequence of PfA, P. horikoshii asparaginase (PhA), EcA I and II was done using ClustalW2 (30) . A BLASTp analysis of PfA (NP_579776.1) was also done for identification of conserved active site residues across asparaginases from various sources.
Although crystal structures of various asparaginases are available, as far as thermophilic asparaginases are concerned, the only available crystal structure is that of P. horikoshii [Protein Data Bank (PDB): 1WLS; ref . 31] . Based on this structure, a homology model of PfA was constructed using Swiss-Model (32) . Quality of the model was ascertained using PROCHECK 3.4 (33) as well as by Ramachandran plot analysis (34) . The modeled structure of PfA thus generated was superposed over the structure of EcA II (PDB: 3ECA). Critical residues for mutation were identified based on nonoverlapped regions of the enzyme active site. The lowestenergy rotamer for each mutated residue was chosen using the Swiss PDB Viewer (35) to generate 3 mutant structures, namely, single-mutant T53Q, K274E, and a double-mutant T53Q/K274E. All the figures were made using PyMOL 1.3 (36) and Accelrys Discovery Studio Visualizer 2.5 (Accelrys, Inc., San Diego, CA, USA).
Development of mutants
The PfA clone prepared in our laboratory previously was used as a template for PCR-based site-directed mutagenesis (37) . The oligonucleotide sequences (Sigma, St Louis, MO, USA) used to construct the site-directed mutants were 5Ј-GGAGTTGATCTAACGAG-GTACGAAGTTGGGAGATTAGCC-3Ј and its complementary pair for the K274E single mutant, and 5Ј-GATTTAAAGAACGTT-GATAGCCAGCTTATCCAGCCAGAAGATTGG-3Ј and its complementary pair for T53Q single mutant. For the double-mutant T53Q/K274E, the T53Q primer pair was used over the template of K274E mutant. The bases indicated in bold code for the desired amino acid change. DpnI (Fermentas, Burlington, ON, Canada)-treated PCR products were transformed in competent E. coli Rosetta (DE3) cells for expression. The mutations were further verified by DNA sequencing.
Expression and purification of proteins
Following expression, each of the mutants was purified by Ni-NTA affinity chromatography (Qiagen, Hilden, Germany) using previously described method (29) . Protein concentration was determined by Bradford's method (38) and by UV absorbance using ε 280nm ϭ 27,515 M Ϫ1 ⅐ cm
Ϫ1
. Molecular mass and multimericity of the purified protein were determined by denaturing gel electrophoresis (12% SDS-PAGE), MALDI-TOF mass spectrometry, and gel-filtration chromatography.
Enzyme assay
l-Asparaginase activity was measured as described previously using Nessler's reagent (Merck, Darmstadt, Germany; ref. 29) . One international unit of l-asparaginase activity is defined as the amount of enzyme liberating 1 mol NH 3 in 1 min at specified conditions. Specific activity of l-asparaginase is defined as the units per milligram protein. Glutaminase activity was determined using l-glutamine (SRL, New Delhi, India) as substrate in place of l-asparagine (Thermo Fisher, Waltham, MA, USA) at physiological conditions. Since this method is less sensitive, a modified NADH-dependent coupled enzymatic assay (39, 40) was also used. This assay was carried out in 2 consecutive steps: In the first step, reaction mixture (1 ml) containing 50 mM sodium phosphate buffer (pH 7.4), 10 mM substrate (l-asparagine or l-glutamine), and an appropriate amount of enzyme was incubated for 10 min at 37°C, followed by addition of 100 l of 3 M HCl to stop the reaction. In the second step, 600 l of this reaction mixture was added to a test tube containing 100 mM Tris-Cl (pH 9.0), 2 mM ␤-NADH (Spectrochem, Mumbai, India), and 3.3 mM ␣-ketoglutarate (Sigma) in a total volume of 3 ml. Glutamate dehydrogenase enzyme (22 U; Sigma) was added to the mixture, and the disappearance of ␤-NADH was monitored spectrometrically at 340 nm. Using the molar extinction coefficient of ␤-NADH (6220 M Ϫ1 ⅐cm Ϫ1 ), the activity of enzymes was measured.
For assaying activity of guanidine hydrochloride (GdnCl)-containing samples, a reaction mixture containing 20 l preincubated enzyme in 50 mM Tris-HCl (pH 8.0) and 0.4 mM l-aspartic acid ␤-hydroxamate (AHA; Sigma), in 1 ml final volume was incubated for 10 min at 50°C (AHA method; ref. 22) . A 200-l aliquot from the reaction mixture was added to 50 l of 1.5 M TCA to stop the reaction. Subsequently, 1 ml of oxin/sodium carbonate reagent [1 vol of 2% w/v 8-hydroxyquinoline (Sigma) in absolute ethanol and 3 vol of 1 M Na 2 CO 3 ] was added and heated on boiling water for 1 min to develop the color, the absorbance of which was measured at 705 nm after cooling. Absorbance of samples without GdnCl (Sigma) was taken as 100%.
Enzyme kinetics
Steady-state enzyme kinetics was measured in triplicates in 50 mM Tris-HCl (pH 8.2) at 80°C and 50 mM sodium phosphate buffer (pH 7.4) at 37°C by varying the concentration of l-asparagine in a range of 0.5-80 mM. The kinetic parameters, such as K m and V max , were calculated by fitting to substrate inhibition model kinetics (Eq. 1) by nonlinear least-squares fit using Origin 8.0 software (OrigenLab, Northampton, MA, USA):
where V represents enzyme activity, V max represents maximal activity, S is the substrate concentration, K m is the MichaelisMenten constant, and K s is the substrate inhibition constant. The activity data were analyzed by plotting the logarithm of activity against the reciprocal of the absolute temperature (range 310 -358 K) and fitted to the Arrhenius equation (Eq. 2):
where E a is the energy of activation, R is the gas constant, and A is the preexponential factor.
Trypsin digestion experiment
Each enzyme (110 g) was incubated with 1000 U of trypsin (Sigma) in 50 mM sodium phosphate buffer (pH 7.4) at 37°C for varying time intervals (0 -120 min) followed by addition of 100 g of trypsin inhibitor (SRL) to stop the reaction. The extent of digestion was monitored by running the samples on SDS-PAGE against untreated protein as control and by assaying activity of the treated samples.
Equilibrium denaturation with GdnCl and urea
For equilibrium denaturation experiments, protein samples (0.6 ml final volume) containing 0.2 mg/ml protein in buffer A (25 mM sodium phosphate buffer, pH 7.4, and 20 mM NaCl) and with varying concentrations of denaturant (GdnCl or urea) was prepared. Following overnight incubation, fluorescence and far-UV circular dichroism (CD) spectra of the samples were recorded in a LS 55 spectrofluorimeter (Perkin Elmer, Wellesley, MA, USA) and Jasco J-810 spectropolarimeter (Jasco, Inc., Easton, MD, USA), respectively. For fluorimetry, emission scans of samples taken in a 1-cm cuvette were recorded from 300 to 400 nm following excitation at 280 nm. For CD spectroscopy, samples were taken in a 0.1-cm cuvette and scanned over a range of 200 -250 nm at 50 nm/min scan speed. Three scans for each sample were taken and averaged. Baseline (without protein) was recorded and subtracted from respective experimental samples.
Molecular dynamics (MD) simulations
MD simulations were carried out using the AMBER 11 package (41) on a 320-processor SUN Microsystems cluster at the Supercomputing Facility (SCFBio), Indian Institute of Technology Delhi. The proteins were initially neutralized by adding an appropriate number of counter ions and solvated with TIP4PEW water in an octahedron box (12 Å distance between the protein and the box boundary; ref. 42) . A 250-step energy minimization of the protein structures using a Sander module in the steepest descent was done, followed by a 750-step minimization in conjugate gradient. Further slow heating (from Tϭ0 to 310 K in 62 intervals) of each system was carried out for equilibrating solute molecules, keeping the configurations of solvent molecules fixed. Each system was then equilibrated at 310 K for 310 ps, followed by MD simulation for 12 ns at 310 K, keeping a periodic boundary condition in the NPT ensemble with Berendsen temperature coupling (43) and constant pressure P ϭ 1 atm with isotropic molecule-based scaling. During simulations, the Shake algorithm (44) for fixing all covalent bonds containing hydrogen atoms and the particle mesh Ewald (PME) method (45) to treat long-range electrostatic interactions were utilized. The time step of simulations was 1 fs with a cutoff radius of 10 Å for the nonbonded interactions. The coordinates of the trajectory were saved every 2.5 ps of the simulation. The ptraj module of AMBER and the VMD software package (46) were utilized to process the coordinate files generated during the MD simulations.
Cytotoxicity studies
A standard MTT assay (47) was performed for determining antiproliferative effects of PfA variants against cell lines HL60, K562 (leukemic), MCF7 (breast cancer), and peripheral blood mononuclear cells (PBMNCs; noncancerous cells). Cells (5ϫ10 3 /well) of each type were incubated in 100 l of RPMI 1640 (Life Technologies, Gaithersburg, MD, USA) supplemented with 10% FCS (Life Technologies), 2 mM l-glutamine, and various concentrations of the mutant enzymes and EcA II at 37°C and 5% carbon dioxide. MTT dye solution (20 l from 5 mg/ml stock in PBS, pH 7.4; Sigma) was added to each well 4 h before completion of incubation (72 h). The formazan crystals formed as a result of cellular reduction of MTT were dissolved in DMSO (Sigma) and read on an ELISA reader using a 540-nm filter. All measurements were done in triplicate and represented as percentage relative cell viability.
RESULTS
Selection of amino acid for site-directed mutagenesis
PfA showed 66% sequence identity with the PhA, and 22% with EcA II. A homology model of PfA was generated with appropriate quality checks (Fig. 1A) . Superposition of PfA and EcA II structures revealed that, except for 3 regions, most of the regions overlapped well. These nonoverlapping regions were the C terminus, the linker region, and the flexible loop of the active site (Fig. 1B) . Of these, the flexible loop region of EcA II and a corresponding stabilized ␤-hairpin loop region of PfA were considered to impart catalytic property to the respective enzymes. The aligned structure also showed that most of the active site residues of PfA and EcA II superpose nicely (Fig. 1C) .
From structural analysis, it was found that Lys274Ј present at C␣3Ј helix (representing one monomer) interact strongly to the neighboring ␤-hairpin loop via a salt bridge with Glu22 residue and through an H bond with Tyr21 residue (representing the other monomer). These interactions might be stabilizing the loop and restricting the accessibility of substrate to the active site (Fig. 1D) . In contrast to Lys274Ј of PfA, a Glu283Ј was found at the corresponding position in EcA II (Figs. 1C and 2) . Therefore, to make the PfA active site similar to EcA II, Lys274 was selected for replacement with Glu residue. From similar analysis, a second position 53 was identified where a Thr in the PfA primary structure was present in place of Gln of EcA II (Figs. 1C and 2 ). This Gln has been reported to be involved in substrate binding in EcA II and other type II enzymes (22) . Thus, changes in Lys274 and Thr53 of PfA to Glu and Gln, respectively, were likely to create an active site pocket closely matching with that of EcA II. With the expectation that these changes would make PfA more active at mesophilic conditions, 2 single mutants (T53Q and K274E) and a double mutant (T53Q/K274E) were developed.
Site-directed mutagenesis and purification of mutants
As described above, all 3 mutants of PfA were developed using site-directed mutagenesis and confirmed by DNA sequencing. The proteins were expressed intracellularly and purified using a combination of Ni-NTA affinity chromatography and heat treatment. Purified protein preparations were fairly homogeneous, as they showed a single intense band of ϳ37 kDa on 12% SDS-PAGE. All the proteins remained primarily as dimers, with low-level occurrence of higher multimers, as observed by gel-filtration chromatography (Supplemental Fig. S1 ).
Determination of enzyme kinetic parameters
The effect of mutations on the enzyme activity and substrate affinity was evaluated. Various kinetic parameters of the PfA variants were determined under both optimum conditions (80°C, pH 8.2) and physiological conditions (37°C, pH 7.4). Substrate inhibition with Ն20 mM and Ն30 mM l-asparagine was observed for the mutants when assayed at 80 and 37°C, respectively. Therefore, the kinetic parameters for the mutants were determined using a substrate inhibition model ( Table 1) . All the mutants showed lower K m values than the WT, with K274E being the lowest. Interestingly, all 3 mutants showed 3-4 times reduced turnover at 80°C as compared to the WT, whereas at 37°C, they showed marginal improvement over the WT. Among the variants, K274E was found to be catalytically more efficient, as reflected by k cat /K m value (9.6ϫ10 4 M Ϫ1 ⅐s Ϫ1 ). The improved catalytic efficiency of K274E may be a combined effect of reduced K m value and activation energy of the enzyme (Table 1) . However, a striking contrast in efficiency of WT under these two conditions was found. At physiological conditions, the WT enzyme displayed minimum catalytic efficiency, whereas at 80°C, the value was close to that of K274E.
Glutaminase activity
Under physiological conditions, none of the enzymes showed activity with l-glutamine as substrate. Instability of l-glutamine prevented measurement of glutaminase activity at high temperature (48) .
Stability against proteolytic cleavage (trypsin)
To probe the resistivity of PfA mutants toward proteolytic cleavage, trypsin-treated samples incubated for increasing time periods were monitored by SDS-PAGE, as well by assaying remaining activity (Fig. 3) . Fragmentation patterns on SDS-PAGE showed that both WT and K274E mutants were significantly more resistant than the other 2 mutants. Activity profile, however, suggested that the K274E mutant has lower activity (40%) as compared to the WT. The other 2 mutants showed the lowest residual activity.
Chemical denaturation studies
Fluorescence spectroscopy
Like the WT protein, all the mutants showed em max at 325 nm in their native state (0 M GdnCl), which shifted to 352 nm when completely unfolded (6 M GdnCl). The percentage unfolding with increasing denaturant concentration was plotted as a change in the intensity of em at 325 nm. All the mutants began to lose their structure beyond 2.5 M GdnCl and got completely denatured at 4.5 M GdnCl (Fig. 4A) . Unfolding pattern of the protein when fitted using nonlinear curve fitting followed a 2-state model. The values of cooperativity m and midpoint of unfolding transition [D] 1/2 were obtained from the fitted curve. From linear extrapolation of the transition phase, the ⌬G H2O values for each of the enzymes were calculated (Fig. 4C) . All the parameters obtained through these studies are summarized in Table 2 .
CD spectroscopy
Unfolding transition was also monitored by CD spectroscopy, where changes in signal intensity at 222 nm were plotted as a function of increasing GdnCl concentration. When plotted as percentage unfolding, the pattern matched the trend observed by fluorescence spectroscopy (Fig. 4B) .
Activity measured for the GdnCl-containing samples showed an interesting trend. Regardless of the presence or absence of mutation, all the PfA variants displayed a sharp decrease in activity at GdnCl concentrations as low as 1 M, even before the initiation of unfolding transition (Fig. 4A) . In contrast to GdnCl, urea, even at 8 M concentration, failed to induce any structural change in the enzymes. Consequently, there was no decrease in activity of the urea-containing samples.
Simulation studies
For studying the effect of the mutations on PfA structure, MD simulations were carried out on the modeled structure of PfA and its mutants. The plot of protein backbone RMSD showed that all the structures reached equilibrium after 10 ns of simulations (Fig. 5A) . The total energy for the PfA and its 3 mutant structures, namely, K274E, T53Q, and T53Q/K274E, after 12 ns of MD simulations were Ϫ13894, Ϫ13639, Ϫ13868, and Ϫ13541 kJ/mol, respectively. An overall increase in energy of all 3 mutants compared to the WT indicated a less favorable change due to the mutations. The structural coordinates obtained after 12 ns of simulations showed the presence of a salt bridge between Glu22 and Lys274Ј at both active sites of the WT protein (Fig. 6A) . However, in the case of the K274E and the T53Q/K274E mutants, this particular salt bridge was absent (Fig. 6B, D) . The T53Q mutant showed a salt bridge at only one of the active sites (Fig. 6C) . Also, the Tyr21 (corresponding to Tyr25 of EcA II; Fig. 1C ) was oriented away from the active site in all 4 variants (Fig. 6) . Interestingly, Tyr273Ј was differently oriented in the 2 axially opposite active sites, being closer to the acidic Asp84 (1.6 Å) at site A, and closer to the nucleophile Thr11 (4.3 Å) at site B (Fig. 7) .
Cytotoxicity studies
Dose-dependent survival profiles of human carcinoma cell lines after 72 h treatment with PfA and mutants are shown in Fig. 8 . The noncarcinoma PBMNCs served as control. Leukemic cell lines (HL60, K562) treated with 1 or 0.01 U/ml of PfA variants showed effective reduction in viability as compared to EcA II treatment. Among the mutants, even at 0.001 U/ml, the T53Q and K274E were rather effective in exerting 75 and 60% killing in HL60 cells, respectively (Fig. 8) . Breast carcinoma cell line (MCF7) treated with 1 U/ml PfA variants (with the exception of the T53Q/K274E double mutant) showed considerable reduction in viability. The double mutant displayed ϳ50% survival, matching the effect imposed by EcA II on MCF7 cells up to 0.1 U/ml. Therefore, comparison of all the cytotoxicity data supported that PfA and its mutants pose better antiproliferative activity as compared to EcA II.
DISCUSSION
It was previously shown from our laboratory that PfA is a highly stable enzyme and functions as a homodimer, acting optimally at elevated temperatures (29) . With the objective to make PfA more active at mesophilic conditions and extend its therapeutic and industrial applications, we modified the enzyme and developed 3 new mutants. In the process, we not only developed some efficient cytotoxic l-asparaginase but got valuable ⌬G H2O is the free energy change at 0 M GdnCl, m corresponds to the slopes of the free energy plots, and ͓D͔ 1/2 is the denaturant concentration at the midpoint of melting transition.
insights about the active site of thermophilic asparaginases.
Enzymatic activities of the mutants measured both at physiological (37°C) and optimum (80°C) temperature showed lower K m values as compared to the WT. The effect was particularly pronounced in the case of K274E mutant, which showed ϳ2.5-fold higher catalytic efficiency, reduced activation energy, and 2-fold lower K m as compared to the WT at 37°C ( Table 1 ). The K m values obtained were closer to those of some mesophilic asparaginases (10 M to 2 mM; refs. 2, 11, 49). These effects may be explained due to breakage of specific salt bridge, resulting in increased substrate accessibility, as found in the simulated structure (Fig. 6A, B) . A similar observation has been reported for thermophilic acylphosphatase (50) . At this temperature, the K m for T53Q was comparable to the WT, indicating equivalent substrate accessibility. Here the simulated structure showed salt bridge at only one active site (Fig. 6C) , indicative of differential substrate accessibility at both the active sites. Altogether an average accessibility similar to the WT was observed. Like K274E, the double mutant T53Q/K274E showed ϳ1.5 times decrease in K m as compared to the WT, which is because of absence of salt bridges at the active sites, as evidenced in its simulated structure (Fig. 6D) .
As compared to 80°C, k cat at 37°C was quite low for all 3 mutants. Reports on certain classes of enzymes suggested that their rate of activity is controlled by conformational flexibility instead of traditional ligand binding (51) . Enzymes possessing an active site loop structure that functions as a lid against substrate accessibility undergo temperature-mediated flexibility. Comparison of structural and enzymatic characteristics of such enzymes obtained from hyperthermophilic and mesophilic sources has supported this view (52) . This may be the case for PfA, where the ␤-hairpin loop/lid remains closed at 37°C and opens at high temperature. Notably, in PfA this lid also harbors a critical catalytic residue, Thr11. In this regard, it may be assumed that following initial opening for substrate entry, the loop closes on the substrate, extending the much required catalytic residues (Fig. 1C) . These assumptions were supported by the insights based on MD simulated structures as presented.
Lower effectiveness of EcA II/ErA treatment has been attributed to proteolytic digestion, resulting in premature inactivation and early removal from the body (1.24 d; refs. [53] [54] [55] . In contrast, the PfA variants showed significant resistance against trypsin digestion. Similarity in the fragmentation pattern of the K274E mutant and the WT may be attributed to the K to E substitution, which removes one of the potential trypsin cleavage sites. High stability of PfA and its mutants against trypsin digestion supports the possibility of increased half-life in vivo, and late clearance.
All the PfA variants showed GdnCl-mediated reversible unfolding. The unfolding/refolding data fitted well into a 2-state model, and the stability parameters calculated thereby were suggestive of fairly stable proteins (Table 2) . Extensive ionic interactions contribute to the observed stability, which when broken by GdnCl (and not by urea) brings about structural perturbation. Interestingly, at low GdnCl concentration (1.0 M), a drastic activity loss was observed without any noticeable secondary structure change. This is not unusual, as there are reports suggesting that active sites are more flexible than other parts of the protein and get easily perturbed (56, 57) . Alternatively, activity loss may be due to reversible inhibition of active site residues by denaturants (58) . Superposable near-UV CD curves of PfA variants indicate that there was no apparent tertiary structure change at GdnCl concentration below the unfolding transition (Fig. 4D) . In addition, the stability of the active site is supported by the observed increase in activity with rise in temperature. Together, it confirms that low GdnCl-mediated activity loss is due to reversible inhibition by denaturant. In our case, it was found to be noncompetitive inhibition (Supplemental Fig. S3) .
It is reported that l-asparaginase-treated patients often encounter side effects due to an associated glutaminase activity (26, 59 -61) . Attempts to reduce glutaminase activity of EcA II and ErA gave limited success, but complete elimination has not yet been achieved (22, 62) . In our case, the PfA variants were found to be devoid of glutaminase activity. This may be due to relatively solid rigid 3-dimensional structure of thermophilic enzyme active site, limiting accommodation of the extra CH 2 group of glutamine as compared to asparagine.
The primary objective of developing PfA and its mutants was to obtain a stable, proteolysis-resistant, highly substrate specific antileukemic agent. The mutants K274E and T53Q were found to be extremely cytotoxic, particularly against HL60 cell lines, at concentrations as low as 0.001 U/ml. To obtain the same effect, both the WT and the double mutant required 10-fold higher enzyme concentrations, whereas EcA II required 1000-fold higher concentrations (Fig. 8) . Notably, the activity was found to be more pronounced on leukemic cells, as compared to nonleukemic cells, and was insignificant on normal PBMNCs. In each case, killing by EcA II never matched the values obtained for PfA enzymes, even at high concentrations. These data placed all the PfA variants as superior antileukemic agents compared to EcA II under the mentioned experimental conditions.
In the absence of crystal structure, MD simulations were carried out on the modeled structures of PfA variants. The dimeric interface of PfA holds 2 axially opposite active sites. Earlier reports on l-asparaginases with 2 interfacial active sites suggest that each active site consists of catalytic triads I and II (63, 64) . These triads work in concert to bring about the substrate hydrolysis and product release, respectively. In the first step of catalysis, an acidic residue of triad I activates a base by extracting H ϩ . The base then activates a nucleophile that covalently binds the substrate in an acyl-enzyme intermediate and releases ammonia (acylation). In the second step, an activated nucleophile of catalytic triad II activates a water molecule that functions as second nucleophile and causes the release of product and free enzyme (deacylation) (63) . From sequence and structure analysis, it emerged that the residues for catalytic triad II are fairly conserved, whereas in triad I, Thr11 is the only conserved residue in PfA and other sequencerelated enzymes. The conserved residues of triad II are Asp84 (acid), Lys154 (base), and Thr83 (nucleophile). Notably, the orientations of Tyr25 of EcA II and Tyr21 in PfA were found to be different in superposed protein structures (Fig. 1C, circled) . In case of EcA II, it was found to be projecting toward and into the catalytic triad I, whereas in the case of PfA (and PhA), it was found to be projecting outward from the catalytic plane. In addition, Tyr21 and Lys274, being nonconserved residues, are least likely to be involved in the catalytic mechanism as a member of triad I. Moreover, they do not form the canonical acid-base pair for catalysis. So, for finding an equivalent pair, a BLASTp analysis was done. The residues Asp51, Ser52, Thr53, Asp84, Asp269, and Tyr273 conserved at the dimeric interface consisting of the active site cavity were taken into consideration. The possibility of these residues being part of the catalytic triad I was analyzed using the structural coordinates generated via MD simulation.
The spatial proximity of Tyr273Ј, Asp84, and Asp51 made way for analyzing possible interaction involving these residues at the catalytic center of the enzyme. The Tyr 273Ј was, however, found closer to Asp84 at one active site and to Thr11 at the other active site and far from Asp51 at both active sites (Fig.7) . Close inspection of the crystal structure of PhA also revealed the same. The variation of distances between these residues along the trajectory also confirmed the findings (Fig. 5B, C) . Thus, Tyr273Ј and Asp84 emerge as the only contenders fulfilling the requirements of an acid-base pair of the catalytic triad I. Moreover, the possibility of Tyr21 getting activated by any of the 2 conserved acidic residues Asp51 and Asp84 (Fig. 5D, E) , was ruled out due to large distance (Ͼ10 Å) between them.
The distances between the key residues of the catalytic triad I skewed by orientation of Tyr273Ј raise questions about the possible mechanism of action. The mechanism, however, could be explained by dynamic flipping of Tyr273Ј around its 1 angle, bringing it closer to either Thr11 or Asp84 at any given time. The catalytic mechanism then follows the canonical acidbase-nucleophile coordination, where Asp84 extracts H ϩ from the Tyr273Ј, which further activates Thr11. At high temperature, increased frequency of this dynamic alteration explains higher activity of PfA under these conditions. This mechanism is well supported by a drastic reduction in activity (95% reduction in activity compared to WT) of a mutant in which the Tyr273 was replaced by Ala (Supplemental Fig. S4 ). This is different from the known catalytic triads of other asparaginases, consisting of separate residues for both the triads. These findings gave significant mechanistic insights and await confirmation through NMR in the presence of substrate.
